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Microglia have been implicated in both physiological and pathological processes of the brain. Their possible 
roles have been compared to those of macrophages and granulocytes. Here we demonstrate the specific abili- 
ty of microglia to secrete the superoxide radical ion in response to a complement activated agent, opsonized 
zymosan, and to phorbol myristate acetate. As in other organs, this endogenously produced reactive oxygen 
intermediate could have both beneficial and deleterious effects. 
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1. INTRODUCTION 
The role of microglia in inflammatory and non- 
inflammatory pathological processes in the central 
nervous system (CNS) is not clear. Del Rio 
Hortego [l] and others [2-41 have suggested that 
microglia accumulate at the site of neuronal 
damage where they serve as CNS-specific 
macrophages. Since cultured microglia exhibit 
phagocytosis [3-51, it is possible that one of their 
actions in the CNS is to ingest cellular debris at the 
injured site. Although debated [6,7], evidence to 
support this role of microglia stems from the fact 
that these cells have many of the same anatomical, 
biochemical and specific surface markers as cir- 
culating monocytes [2-4,8-lo]. Because of the 
similarity of microglia to monocytes and to tissue 
macrophages it is also possible that microglia may 
serve to kill invading organisms. It is well known 
that monocytes, macrophages and neutrophils 
secrete reactive oxygen intermediates, e.g. the 
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superoxide anion “(0; -), hydrogen peroxide 
(HzOZ), and oxidized halides, e.g. HOC1 [ll-131. 
These highly reactive compounds plus the hydroxyl 
free radical (OH-) (produced by interaction of 
superoxide and hydrogen peroxide in the presence 
of metal ions) have been shown to be very effective 
bactericidal agents [lo]. Microglial secretion of 
reactive oxygen intermediates could thus serve as a 
protection against infective organisms in the CNS. 
We examined the ability of microglia to secrete ox- 
ygen intermediates by exposing cultured microglia 
cells to activating agents and assaying for superox- 
ide anion production. 
2. MATERIALS AND METHODS 
Primary glial cell cultures were prepared from 
2-day-old rat cerebral hemispheres essentially as 
described [5,14,15]. The cortices were removed 
and placed in Leibovitz’s (L-15) medium. Using a 
binocular microscope, the meniniges and any 
blood vessels were carefully removed thus limiting 
contamination of the culture with blood 
monocytes. The cortices were then placed in fresh 
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L-15, mechanically dissociated and plated into 75 
cm* Falcon flasks. Cells were grown at 37°C in a 
10% carbon dioxide, 90% air environment using a 
modified Dulbecco’s medium (DMEM) containing 
10% fetal calf serum. These conditions were not 
favorable to neuronal growth [14]. After lo-14 
days, the flasks were placed on a rotary shaker 
(200 rpm) and shaken for 15-20 h at 37°C. The 
superantant containing loose cells was collected, 
centrifuged and the cells resuspended in DMEM. 
This method produced a cell fraction composed 
from 70 to 90% microglia. Microglia were iden- 
tified by standard histochemical and fluorescent 
antibody techniques [16-181 and were shown to be 
positive for non-specific esterase, a monocyte 
marker [ 181, and negative to peroxidase (a second 
monocyte marker [19]) in the resting (non- 
activated) state and negative to the following 
specific glial antibodies; GFAP, AzBs and galac- 
tocerebroside (Gale). The results from the 
histochemical and fluorescent antibody techniques 
support the idea that microglia, like other resident 
macrophages, are derived from blood borne 
monocytes but may assume different characteris- 
tics (e.g. peroxidase negative at rest) once in the 
tissue [ 191. 
The microglia-enriched fraction was counted 
and seeded at variable densities into 96well culture 
dishes. The adhered cells remaining in the flask 
were removed by scraping, centrifuged and also 
resuspended in DMEM. This remaining fraction, 
composed primarily of type I (GFAP positive) and 
type II, (GFAP and AzBs positive) astrocytes, was 
also counted and seeded at the same densities as 
the microglia fraction in 96-well culture dishes. 
After adhering overnight, the cells in each well 
were assayed for superoxide using a microcyto- 
chrome c reduction assay developed by Pick and 
Mizel [20]. Specificity for superoxide anion is pro- 
vided by comparing the amount of cytochrome c 
reduction in the presence and absence of superox- 
ide dismutase (SOD), the enzyme which degrades 
superoxide. An automated plate reader (Titer Tek) 
was used to read the absorbance at 550 nm in each 
of the culture wells. Data are expressed as nmol 
superoxide/mg protein. Protein content of the 
wells was determined by digesting the cells over- 
night at 37°C with 0.1 N NaOH. The Lowry assay 
[21] was used to determine the protein content with 
bovine serum albumin as the standard. 
3. RESULTS AND DISCUSSION 
The production of superoxide by the microglia- 
enriched fraction under resting (i.e. non- 
stimulated) and stimulated conditions is shown in 
fig.1. The stimulus for secretion in this case was 
0.5 mg/ml of opsonized zymosan, prepared using 
rat serum in the standard way [22]. Opsonized 
zymosan was chosen as an activating agent because 
it has been shown to stimulate superoxide produc- 
tion in macrophages and neutrophils [22,23]. As 
shown, superoxide concentration increased at a 
rate of 3.7 nmol/mg protein per min until a max- 
imum secretion was reached at about 2-3 h. 
Superoxide secretion in the resting state increased 
only slightly over the same time period. Superoxide 
secretion of the astrocyte fraction is also shown in 
fig.1. In contrast to the microglia, these cells did 
not significantly respond to opsonized zymosan by 
secreting superoxide. In addition to being specific 
to this cell type, superoxide production by the 
microglia-enriched fraction varied with cell density 
(fig.2) and concentration of stimulant (fig.3). 
Finally, the microglia were responsive to stimula- 
tion by phorbol myristate acetate (fig.4) but not to 
stimulation by concanavalin A (from 10 to 100 
pg/ml) or by formylmethionylleucylphenylalanine 
(f-Met-Leu-Phe) (from 10e8 to 10m5 M). 
These results suggest hat microglial production 
of superoxide has many of the same characteristics 
as neutrophil or monocyte superoxide production. 
In other words, superoxide secretion can be 
stimulated by both membrane-associated comple- 
ment factors (e.g. opsonized zymosan) and by 
phorbol esters. These activating agents have been 
extensively examined for both neutrophils and 
monocytes [12,13,22-251. In addition, the rate of 
superoxide secretion is similar to that seen in 
neutrophils and monocytes where values ranging 
from 1 tot 4 nmol/mg protein per min are found 
[23]. However, not all agents which activate 
neutrophils or monocytes, i.e. concanavalin A or 
f-Met-Leu-Phe, induced superoxide production in 
microglia. This suggests that, at least at this stage 
of development, microglia have unique 
characteristics. 
The presence of a superoxide producing cell in 
the CNS may have significant functional conse- 
quences. For example, the amount of superoxide 
released by the microglia into the relatively con- 
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Fig.1. Production of superoxide by cultured glia. Data 
points represent he average concentration of superox- 
ide/mg protein (f SE) produced over 4 h by a 
microglial-enriched cell fraction at rest (i.e. 
unstimulated) (0  and after stimulation by 0.5 mg/ml 
opsonized zymosan (0) and by an astrocyte-enriched 
fraction after stimulation by 0.5 mg/ml opsonized 
zymosan (A) and at rest (A). Number of wells assayed 
(n) equals at least 8. 
fined extracellular spaces of the CNS is equivalent 
to those concentrations of superoxide secreted by 
neutrophils and monocytes [23,26]. Microglia, 
thus, are likely to serve a similar anti-infective 
function but are specific to the CNS. However, 
superoxide secretion can also have deleterious ef- 
fects as shown in peripheral tissues uch as the lung 
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Fig.2. Effect of cell density on superoxide production. 
Values represent he average concentration of superox- 
ide (2 SE) produced with time at three different cell 
densities: (0) 100x lo3 cells/well; (A) 50 x lo3 cells/well 
and (M) 25 x lo3 cells/well. Number of wells assayed (n) 
equals 8. 
Fig.3. Dose response relationship for the effect of op- 
sonized zymosan on superoxide production. Data points 
represent average values ( f SE) for superoxide produc- 
tion/mg protein obtained after 60 min of exposure to 
varying concentrations of opsonized zymosan. Number 
of wells assayed (n) equals at least 6. 
[27,28]. Halliwell and Gutteridge [29,30] have 
recently discussed the possible mechanisms of reac- 
tive oxygen intermediate damage in the CNS. Lipid 
peroxidation of membrane is one potentially im- 
portant damaging action of oxygen intermediates, 
especially in those areas of the brain which are rich 
in transition metals such as iron and copper 
[3 l-341. Consistent with this hypothesis, synaptic 
changes are seen in in vitro neural systems during 
exposure to oxygen intermediates [35,36]. Free 
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Fig.4. Dose response relationship for the effect of phor- 
bol myristate acetate on superoxide production. Data 
points represent he average values (+ SE) for superox- 
ide production/mg protein obtained after 60 min of ex- 
posure to varying concentrations of phorbol myristate 
acetate. Number of wells assayed (n) equals at least 6. 
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radicals have also been implicated in pathological 
alterations of the cerebral circulation as in acute 
severe hypertension [37,38] and in CNS ischemia 
[39]. If microglia have the same ability to secrete 
superoxide in whole brain as in tissue culture, it 
may be reasonable to suggest hat part of the free 
radicals are produced by the microglia. 
Finally, one of the responses to injury in the 
CNS is overgrowth of the damaged area with glia, 
a process called gliosis [2]. Halks-Miller et al. [40] 
have recently shown that a-tocopherol, a lipid 
soluble free radical scavenger, diminishes gliosis 
and reduces neuron damage and loss in mixed 
neuronal/glia cultures. They proposed that the 
trigger for gliosis may involve a free radical 
mechanism, the source of which was not defined. 
One possible source, as indicated by this study, is 
the activated microglia. 
Overall, superoxide secretion by CNS microglia 
is similar to that seen in neutrophils and monocytes 
and could produce both anti-infective and 
deleterious effects. The level of antioxidant protec- 
tion may be the determining factor in balancing the 
potential desirable and undesirable consequences 
of microglia activation. 
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